Skip to main content
Year archive

Haemato AG — 2023 filings

All 13 regulatory filings released by Haemato AG (HAEK) in 2023, sourced directly from the official regulator.

13 Filings
2023 Period
2023 filings (13)
Filing Released Lang
Jahresabschluss zum Geschäftsjahr vom 01.01.2021 bis zum 31.12.2021
Annual Report FY 2021
2023-12-12 German
HAEMATO AG: Termination of listing in the Open Market
Delisting Announcement
2023-11-30 English
HAEMATO AG publishes figures for the third quarter of 2023: Sales increase of around 13% compared to the same period of the previous year, strong increase in EBIT margin and significant increase in
Earnings Release 9M 2023
2023-11-16 English
Termination of the botulinum toxin project
Regulatory Filings
2023-11-15 English
Half-yearly financial statements 2023
Interim / Quarterly Report H1 2023
2023-10-30 English
Half-yearly financial statements 2023
Interim / Quarterly Report H1 2023
2023-10-30 English
HAEMATO AG publishes figures for the first half of 2023
Earnings Release H1 2023
2023-08-31 English
Annual financial statements 2022
Annual Report FY 2022
2023-06-09 English
Annual financial statements 2022
Annual Report FY 2022
2023-06-09 English
HAEMATO AG with a strong start into the year 2023: Revenue increase of over 25% compared to the same quarter of the previous year and disproportionate increase in the operating result
Earnings Release Q1 2023
2023-05-31 English
HAEMATO AG: Dividend of EUR 1.20
Notice of Dividend Amount
2023-05-16 English
HAEMATO AG publishes preliminary figures for the 2022 financial year: Strong increase in net profit and operating cash flow
Earnings Release FY 2022
2023-04-13 English
Konzernabschluss zum Geschäftsjahr vom 01.01.2021 bis zum 31.12.2021
Audit Report / Information FY 2021
2023-02-14 German